Panels

Four ready panels, one chip each: the question each one answers, what is on the chip, and how to read the result.

Four panels

A panel is a set of pre-conjugated ligands on fixed oligo addresses, usually with a built-in reference. The Immune Profiling panel uses all eight addresses for binders. Layout, replicates and controls are designed in advance, so a run can focus on samples and interpretation.

One chip, five steps

  1. 8-plex chip
  2. Oligo panel, pooled
  3. Loading
  4. Titration (SCK)
  5. Regeneration
Chip, pool, load, titrate, regenerate

Choose a panel, then play the five steps or step through them. The chip shows the real address map, and position n of the panel table sits on address n. Then switch the candidate and run the titration again.

In the animation, each address follows a 1:1 model. Protein A/G gets a high affinity, the other ligands a low one, so their response grows mostly at the top concentrations. The titration follows the polyreactivity runs on the developability page. The Fc Receptor, FcRn Species and Immune Profiling panels are not in the selector, because this page does not list which address carries which ligand.

Where the panels fit in antibody development

Developability questions usually need separate platforms. Here each is answered on one chip, with the intact antibody in a relevant matrix. Polyreactivity, Fc receptor and FcRn binding each have a panel; plasma protein binding is an assay that captures the antibody through anti-Fc.

ALL CANDIDATESPolyreactivity

Does it bind surfaces it should not?

SURVIVORSPlasma binding

Does plasma protein bind to it, and does it stay bound?

SHORT LISTFc receptor

How does it engage immune cells?

NOMINATEDFcRn species

How long does it circulate?

Polyreactivity Panel

Does the candidate bind surfaces it should not?

Illustration of three IgG antibodies in purple. One binds a blue protein with a Fab arm, one binds a strand of DNA with a Fab arm, and one binds a blue protein on its Fc region; orange marks each contact.
Off-target contacts of IgG (purple) with proteins and DNA (blue), at the Fab arms and once on the Fc.

Why it matters. Polyreactivity is linked to fast clearance, a short half-life and attrition in clinical development (Jain et al., PNAS 2017). Endpoint assays report it without kinetics and on a separate platform; the panel measures it label-free, on the same instrument as the target kinetics.

Readout. One response per ligand, summarized as a Polyreactivity Index. The fingerprint across the ligands shows which chemistries a candidate binds, and whether the binding is broad or focused. Compare candidates within one run, under identical conditions.

Two formats. Essentials (8-plex, 8 replicates per ligand) for routine triage in every discovery cycle; Plus (16-plex, 4 replicates) for in-depth assessment ahead of lead nomination.

The ligands and why they are there

Each ligand stands for one kind of unwanted interaction: charge, lipid, glycan, plasma protein or nucleic acid. Positions 1 to 8 carry the same ligands on the same oligo addresses in both formats. An Essentials screen and a Plus follow-up therefore give directly comparable results.

Eight tiles, positions 1 to 8, each with a flat symbol, the ligand and its role: Protein A/G (capture control), dsDNA (nucleic acid), HSA (plasma carrier), insulin (small protein), lysozyme (basic protein), aminocardiolipin (anionic lipid), aminoheparin (sulfated polyanion) and AGP (glycosylated protein).
Positions 1 to 8, Essentials and Plus. Symbols, not structures.
Eight tiles, positions 9 to 16, each with a flat symbol, the ligand and its role: alpha-1-antitrypsin, apo-transferrin, C3d, apolipoprotein A-I, GC globulin, beta-2-microglobulin, gelatin and ssDNA.
Positions 9 to 16, Plus only. Symbols, not structures.
#LigandWhat binding to it reveals
Positions 1 to 8 · Essentials and Plus
1Protein A/GControl: confirms the antibody was captured and normalizes each injection. Not a liability axis.
2dsDNAReference surface; also reports nucleic-acid binding, a classic polyreactivity signal.
3Human serum albuminBinding to the main plasma carrier protein.
4InsulinBinding to a small protein; a standard polyreactivity antigen.
5Human lysozymeElectrostatic binding to a basic, positively charged protein.
6AminocardiolipinBinding to an anionic lipid, as found in cell membranes.
7AminoheparinBinding to a sulfated polyanion; flags positively charged patches.
8α1-acid glycoproteinBinding to a heavily glycosylated plasma protein.
Positions 9 to 16 · Plus only
9α1-antitrypsinBinding to an abundant plasma serpin.
10Apo-transferrinBinding to an acidic plasma protein.
11Complement C3dInteraction with the complement system.
12Apolipoprotein A-IBinding to an amphipathic lipoprotein component.
13GC globulinBinding to a vitamin D-binding glycoprotein.
14β2-microglobulinBinding to a small β-sheet protein.
15GelatinBinding to a disordered protein.
16ssDNAA second, flexible nucleic-acid surface.

Fc Receptor Panel

How does the antibody engage immune effector cells?

Illustration of an IgG antibody in purple with an Fc gamma receptor in blue bound near the hinge of its Fc region, other antibodies blurred in the background.
An Fcγ receptor (blue) binds the Fc region of an IgG (purple).

Why it matters. The Fab binds the target; the Fc region engages Fcγ and Fcε receptors on immune cells and so decides on phagocytosis, ADCC and degranulation.

Readout. Kinetics and affinity for each receptor, read as a profile. The balance between activating and inhibitory receptors is more informative than any single value, because Fc receptor binding is weak, avidity-driven and glycan-dependent. Set the profile against cell-based assays such as ADCC and ADCP.

ReceptorSignalDrives
FcγRI (CD64)activatingphagocytosis
FcγRIIa (CD32a)activatingplatelets, monocytes
FcγRIIb (CD32b)inhibitorydamps the response
FcγRIIIa (CD16a)activatingNK cells, ADCC
FcγRIIIb (CD16b)activatingneutrophils
FcεRIactivatingmast cells, allergy
FcεRII (CD23)regulatoryIgE feedback
Oligo onlyreferencechecks binding to the DNA layer

FcRn Species Panel

How long will the antibody circulate, and how does that translate between species?

Illustration of an IgG antibody in purple with two FcRn molecules in blue bound on either side of its Fc region; orange marks the contacts.
Two FcRn molecules (blue) bound to the Fc region of an IgG (purple).

Why it matters. FcRn rescues IgG from lysosomal degradation. It binds in the acidic endosome at pH 6.0 and releases at the cell surface at pH 7.4. This switch sets the serum half-life.

Two panels of an IgG in purple above a membrane with FcRn in blue. Left: the Fc region of the IgG sits on FcRn. Right: an orange arrow shows the IgG leaving FcRn.
Left: IgG bound to FcRn at pH 6.0, in the endosome. Right: IgG released at pH 7.4, at the cell surface.

Readout. Kinetics at pH 6.0 and at pH 7.4, one single-cycle run each. Strong binding at pH 6.0 supports a long half-life; persistent binding at pH 7.4 is a liability, because the antibody is not released.

On the chipRole
Human FcRnClinical reference
Cynomolgus, marmoset FcRnPrimate models
Mouse, rat FcRnRodent models
Minipig FcRnLarge-animal model
Human FcRn L320AIgG-binding-deficient specificity control
Oligo onlyReference for the DNA layer

Immune Profiling Nanobody Panel

Which immune cell markers are present in a sample?

Why it matters. Eight markers resolve the main leukocyte classes: T cells with their helper and cytotoxic subsets, B cells, NK cells and monocytes.

Readout. Binding to each marker-specific nanobody, measured in parallel on one [Oligo|Oligo] 8-plex chip, in whole blood, PBMCs or serum-containing media.

MarkerIdentifies
CD45all leukocytes
CD3εall T cells
CD4helper T cells
CD8cytotoxic T cells
CD19B cells
CD56NK cells
CD14monocytes
CD7T and NK lineage

At about 15 kDa the nanobodies pack densely on the ridges. With one binding domain and no Fc, they add no Fc-mediated background. Each binder comes in its own vial, on the oligo sequence you choose.